3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
5
Active not recruiting
3
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
52
Neoplasms
36
Colorectal Neoplasms
33
Prostatic Neoplasms
31
Carcinoma, Non-Small-Cell Lung
31
Lung Neoplasms
30
Pancreatic Neoplasms
21
Multiple Myeloma
16
Recurrence
14
Ovarian Neoplasms
14
Uterine Cervical Neoplasms
12
Leukemia, Myeloid, Acute
11
Carcinoma, Hepatocellular
11
Neoplasm Metastasis
10
Head and Neck Neoplasms
10
Brain Neoplasms
10
Melanoma
9
Stomach Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
8
Rectal Neoplasms
8
Advanced Solid Tumors
8
Triple Negative Breast Neoplasms
7
Small Cell Lung Carcinoma
7
Glioblastoma
7
Endometrial Neoplasms
7
Carcinoma, Renal Cell
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Glioma
6
Esophageal Neoplasms
6
Colonic Neoplasms
6
Interventions
pembrolizumab
1
enfortumab vedotin
1
Single Person
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Peripheral Nervous System Diseases
×
30 days
×
Clear all
NCT07629700
2026-06-05
ENDEAVOR
University of Florence
Phase NA
Not yet recruiting
40 enrolled